Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 448-452

  Sawathiparnich, Pairunyar ^a   Kumar, Sandeep ^b   Vaughan, Douglas E ^c   Brown, Nancy J ^a,c  

^a Division of Clinical Pharmacology   (United States)

^b Pediatric Endocrinology   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; GLUCOSE; HYDROCHLOROTHIAZIDE; INSULIN; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM; POTASSIUM CHLORIDE; RENIN; SODIUM; SPIRONOLACTONE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FIBRINOLYSIS; HEART RATE; HUMAN; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE BLIND PROCEDURE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 0036172321     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.2.7980     Document Type: Article

References (28)

1. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension
2. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
3. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
4. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
5. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells
6. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV
7. Effect of activation and inhibition of the renin angiotensin system on plasma PAI-1 in humans
8. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production
9. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
10. Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects
11. Re-assessment of plasma angiotensin measurement: Effects of protease inhibitors and sample handling procedures
12. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats
13. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension
14. Pharmacology of diuretics
15. Fibrinolytic function in diuretic-induced volume depletion
16. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis
17. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: Stimulation by glucocorticoids and inhibition by catecholamines
18. Spironolactone, an aldosterone antagonist, acts as an antiglucocorticoid on the mouse mammary tumor virus promoter
19. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism
20. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats
21. Mineralo-corticoid blockade reduces vascular injury in stroke-prone hypertensive rats
22. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats
23. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
24. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
25. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
26. Hydrochlorothiazide impairs fibrinolytic balance in hypertensives
27. Activation of the renin-angiotensin system through dietary sodium restriction increases plasminogen activator inhibitor type 1 levels in essential hypertension
28. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial infarction